% | $
Quotes you view appear here for quick access.

ONYX Pharmaceuticals, AŞ Message Board

  • johnpapas893 johnpapas893 Feb 28, 2013 11:05 AM Flag

    yo-yo trading

    Has this stock become the perfect example of yo-yo technical trading? Why is there no support from its fundamentals?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • The slide today was primarily due to positive developments on Revlimid and Pomalyst, according to analyst write-ups.

      • 1 Reply to basselope777
      • You are probably right. Pomanlyst is approved for the treatment of refractory or relapsed multiple myeloma patients who have tried either Revlimid of Velcade. This is the same subset of patients that Kyprolis is also supposed to treat. Thus, although their undelying mechanisms are quite different (complementary?), still Pomalyst and Kyprolis are "technically' rivals. Unless, it is establised that the combination of Pomalyst and Kyprolis is even more potent--i.e. there are strong synergestic therapeutic effects--the successful take-off of Pomalyst will be viewed by analysts as being negative for Kyprolis. It is probably true that the market is big enough for both drugs. Still, there will be some Kyprolis-displacing effects because of the entry of Pomalyst.

        I would like to know what Vin, Kot and the others think about this.